Your browser doesn't support javascript.
loading
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status.
Fujieda, Shigeharu; Matsune, Shoji; Takeno, Sachio; Ohta, Nobuo; Asako, Mikiya; Bachert, Claus; Inoue, Tomoyuki; Takahashi, Yoshinori; Fujita, Hiroyuki; Deniz, Yamo; Rowe, Paul; Ortiz, Benjamin; Li, Yongtao; Mannent, Leda P.
Afiliación
  • Fujieda S; Department of Otorhinolaryngology-Head & Neck Surgery, Fukui, Japan.
  • Matsune S; Nippon Medical School, Musashi Kosugi Hospital, Kanagawa, Japan.
  • Takeno S; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Ohta N; Department of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Asako M; Department of Otolaryngology, Kansai Medical University, Osaka, Japan.
  • Bachert C; Department of Ear, Nose, and Throat Science, Ghent University, Ghent, Belgium.
  • Inoue T; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
  • Takahashi Y; Sanofi K.K., Tokyo, Japan.
  • Fujita H; Sanofi K.K., Tokyo, Japan.
  • Deniz Y; Sanofi K.K., Tokyo, Japan.
  • Rowe P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Ortiz B; Sanofi, Bridgewater, NJ, USA.
  • Li Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Mannent LP; Sanofi, Bridgewater, NJ, USA.
Allergy ; 77(1): 186-196, 2022 01.
Article en En | MEDLINE | ID: mdl-33993501

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rinitis / Pólipos Nasales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Allergy Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rinitis / Pólipos Nasales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Allergy Año: 2022 Tipo del documento: Article País de afiliación: Japón